Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fatty acid synthase expression in melanoma.

D Innocenzi1, P L Alò, A Balzani

  • 1Department of Dermatology, Institute of Experimental Medicine and Pathology, University of Rome La Sapienza, Rome, Italy. daniele.innocenzi@uniroma1.it

Journal of Cutaneous Pathology
|January 22, 2003
PubMed
Summary

Fatty acid synthase (FAS) is a reliable prognostic marker in human melanomas. High FAS expression, especially with increased Breslow thickness, indicates a poorer prognosis and may guide treatment decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Popularity of heated-tobacco products and e-cigarettes among medical school students in Rome, Italy: factors associated with use and attitudes towards quitting.

La Clinica terapeutica·2025
Same author

The Art of Observation - How Art Enhances Healthcare Professionals' Skills.

La Clinica terapeutica·2025
Same author

Vaccination plays a fundamental role in healthcare personal health and safety.

La Clinica terapeutica·2025
Same author

Validation of a Questionnaire to Assess Nursing Students' Knowledge in Critical Care.

La Clinica terapeutica·2025
Same author

Validation of the Self Awareness Outcome Questionnaire (SAOQ) in the Italian framework.

La Clinica terapeutica·2024
Same author

Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial).

Trials·2024

Area of Science:

  • Oncology
  • Biochemistry
  • Dermatology

Background:

  • Fatty acid synthase (FAS) is crucial for fatty acid synthesis.
  • FAS is weakly expressed in normal tissues but overexpressed in aggressive carcinomas.
  • Overexpression of FAS is linked to poor outcomes in various cancers.

Purpose of the Study:

  • To investigate the prognostic significance of FAS in human melanoma.
  • To evaluate FAS expression in primary melanomas and metastases.
  • To correlate FAS expression with patient outcomes and Breslow thickness.

Main Methods:

  • Immunohistochemistry using a monoclonal anti-FAS antibody.
  • Analysis of 77 primary melanomas, 30 metastases, and 30 nevi (controls).
  • Five-year follow-up of all patients.

Related Experiment Videos

Main Results:

  • Strong FAS immunostaining was observed in 34 melanomas and all metastases.
  • All patients with metastases died within the follow-up period.
  • FAS expression intensity significantly correlated with Breslow thickness (p=0.012) and prognosis (p=0.049).

Conclusions:

  • Fatty acid synthase (FAS) is a dependable prognostic indicator in human melanomas.
  • Combining FAS expression with Breslow thickness enhances its predictive power.
  • FAS evaluation can aid in patient stratification for closer monitoring and tailored therapies.